Clinical Trials Directory

Trials / Completed

CompletedNCT03115502

Hemodynamic Changes and Vascular Tone Control After Bariatric Surgery

Hemodynamic Changes and Vascular Tone Control After Bariatric Surgery. Prognostic Value Regarding Hypertension and Target Organ Damage

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Parc de Salut Mar · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Obese patients have increased cardiovascular risk and target organ damage (TOD) as compared to people with normal weight. Weight loss reduces cardiovascular risk and TOD. These changes have been associated mainly to changes in inflammatory and pro-atherogenic markers. Office peripheral blood pressure (BP) appears to decrease after bariatric surgery, but information on changes in 24h-ambulatory-BP-monitoring (24h-ABPM) and central-BP(cBP), or about the possible role of renin-angiotensin-aldosterone (RAAS), serotonin(STS) and endocannabinoid(ECS) systems is scarce. Our hypothesis is that the hemodynamic changes mediated by alterations in the RAAS, STS and ECS after weight loss are also responsible for the reduction of TOD.

Conditions

Timeline

Start date
2013-08-01
Primary completion
2018-12-01
Completion
2019-04-01
First posted
2017-04-14
Last updated
2020-03-05

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03115502. Inclusion in this directory is not an endorsement.